On the one hand, a DNA analysis in blood, brain tissues, or blood lymphocytes from subjects included in the Quebec Founder Population cohort reported no association of PCSK9 LOF mutations with AD prevalence or onset [120]. This evidence concerns the gene PCSK9 and Alzheimer disease.